In this June 22, 2015, photo, a tablet of flibanserin sits on a brochure for Sprout Pharmaceuticals in the company's Raleigh, N.C., headquarters. Sprout soon may succeed where many of the world’s largest pharmaceutical companies have failed: in winning Food and Drug Administration approval for flibanserin, dubbed Addyi, the first drug to boost women’s sexual desire. (AP Photo/Allen G. Breed)